Prot#GED-0301-CD-004:A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects with Crohn’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/17 → 12/22/18

Funding

  • Quintiles, Inc. (Prot#GED-0301-CD-004 // Prot#GED-0301-CD-004)
  • Celgene Corporation (Prot#GED-0301-CD-004 // Prot#GED-0301-CD-004)